【抗體】《AbbVie》和《BigHat Biosciences》 利用AI開發下一代「抗體」治療

 【抗體】《AbbVie》和《BigHat Biosciences》 利用AI開發下一代「抗體」治療

 文章出處  

Aithority 

 

 原文標題  

AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies 

 

 Twitter  

https://twitter.com/aimedadviser/status/1733470935129436432 

 

 文章序號  

4801 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.